PDCD1 and glioblastoma: As shown in the figure, neither programmed cell death protein 1 (PD-1) nor cytotoxic t lymphocyte antigen 4 (CTLA4) was significant for treatment in the risk group (Fig. S4C), probably due to the very poor prognosis of GBM.